87. Eur J Surg Oncol. 2018 Aug;44(8):1139-1141. doi: 10.1016/j.ejso.2018.06.007. Epub2018 Jun 18.Inflammatory Breast Cancer: What surgeons need to know.Rafnsdóttir SL(1), Audisio RA(2).Author information: (1)Oncoplastic Breast Surgery, Department of Surgery, Landspitali UniversityHospital, 13-A Hringbraut, IS-101, Reykjavik, Iceland; Department of Surgery,Institute of Clinical Sciences, Sahlgrenska University Hospital, Blå Stråket 5,413 45, Göteborg, Sweden. Electronic address: svanhra@landspitali.is.(2)Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, Blå Stråket 5, 413 45, Göteborg, Sweden. Electronic address:raudisio@doctors.org.uk.Strict criteria to identify Inflammatory Breast Cancer (IBC) have been madeavailable - these are based on pathological as well as clinical observations. It is mandatory to confirm the criteria used in any further report. Scientificevidence accumulated so far is confusing, and unclear therefore no hardconclusion can be drawn from the available literature on the management of IBC.The advent of new medications results into an up-to-date management and differentoutcomes. It is mandatory to follow these criteria if reliable guidelines are to be made available in the next future.Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and theEuropean Society of Surgical Oncology. All rights reserved.DOI: 10.1016/j.ejso.2018.06.007 PMID: 29954638  [Indexed for MEDLINE]